Table 2: Baseline characteristics of the study population. (N = 275). |
|
Characteristics |
Experimental group |
Sex |
|
Men |
150 |
Woman |
125 |
Age (years) |
56 ± 10 |
LVEF, (%) |
40 ± 4.8 |
Size, (m) |
1.63 ± 14 |
Weight, (kg) |
84 ± 10.7 |
BMI |
34 ± 3.1 |
Abdominal circumference, (cm) |
93 ± 7.5 |
Fat* |
29 ± 4.4 |
Muscle* |
32 ± 9.1 |
Force, (kg) |
27 ± 9.3 |
Sarcopenia* |
32% |
Calf circumference |
37.9 ± 11.5 |
Cholesterol, (mg/dL) |
195 ± 13.5 |
Triglycerides, (mg/dL) |
130 ± 12.7 |
LDL, (mg/dL) |
118 ± 23.4 |
HDL, (mg/dL) |
41 ± 3.6 |
Fasting glucose, (mg/dL) |
135 ± 11.3 |
Estimated VO2 |
7.5 ± 5.7 |
METs |
2.1 ± 1.6 |
Fatigue (FACT-F) |
16.3 ± 9.7 |
Quality of life |
108 ± 14.0 |
Distance traveled |
243 ± 23.0 |
MHR in stress test |
156 ± 12.0 |
Overweight and/or obesity* |
78 |
Abdominal obesity* |
88 |
Dyslipidemia* |
25 |
Arterial hypertension* |
31 |
Diabetes mellitus* |
56 |
Renal disease* |
11 |
Sedentary lifestyle*,‡ |
91 |
Depression* |
57 |
Anxiety* |
18 |
Smoking* |
40 |
Alcoholism* |
15 |
Improper diet* |
56 |
MI history* |
4 |
Sex female* |
45 |
Age,*,§ |
5 |
FACT-F = functional assessment of cancer therapy fatigue. mg/dL = milligrams/deciliters. METs = metabolic equivalent. MHR = maximum heart rate. * Percentage. ‡ Less than 150 minutes per week. § Over 60 years old. |